Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
about
MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axisrs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population.New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review
P2860
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@ast
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@en
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@nl
type
label
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@ast
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@en
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@nl
prefLabel
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@ast
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@en
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@nl
P2860
P3181
P356
P1476
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
@en
P2093
Jesus Garcia-Foncillas
P2860
P304
P3181
P356
10.1155/2016/4873089
P407
P577
2016-01-01T00:00:00Z